Literature DB >> 8856421

Quantitative EEG in the prediction of antidepressant response to imipramine.

V J Knott1, J I Telner, Y D Lapierre, M Browne, E R Horn.   

Abstract

The purpose of this study was to examine the utility of quantitative electroencephalography (QEEG) in the prediction of response to imipramine in depressed patients. Forty patients with a diagnosis of unipolar depression were subjected to a placebo washout and were assessed at pre-drug, 3 h after their first dose of imipramine, and again 2 weeks into treatment. Following 4 weeks of open imipramine treatment, patients were separated into responder (R) and non-responder (NR) groups. Statistical analysis of the 29 patients who completed the study focused on group comparisons of power spectral estimates in four frequency bands from multi-channel recordings. Results showed that theta power differentiated R and NR groups prior to treatment, in response to an acute test dose, as well as after 2 weeks of active drug treatment. Results based on this exploratory study suggest that QEEG may be a useful early predictor of response to imipramine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8856421     DOI: 10.1016/0165-0327(96)00003-1

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  23 in total

1.  Neuronal generators of posterior EEG alpha reflect individual differences in prioritizing personal spirituality.

Authors:  C E Tenke; J Kayser; L Miller; V Warner; P Wickramaratne; M M Weissman; G E Bruder
Journal:  Biol Psychol       Date:  2013-08-30       Impact factor: 3.251

2.  Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings.

Authors:  Gerard E Bruder; James P Sedoruk; Jonathan W Stewart; Patrick J McGrath; Frederic M Quitkin; Craig E Tenke
Journal:  Biol Psychiatry       Date:  2007-12-03       Impact factor: 13.382

3.  An Electrophysiological Biomarker That May Predict Treatment Response to ECT.

Authors:  Katherine W Scangos; Richard D Weiner; Edward C Coffey; Andrew D Krystal
Journal:  J ECT       Date:  2019-06       Impact factor: 3.635

4.  Biomarker Development for Brain-Based Disorders: Recent Progress in Psychiatry.

Authors:  James O Ebot Enaw; Alicia K Smith
Journal:  J Neurol Psychol       Date:  2013-11-01

Review 5.  Multimodal approaches to define network oscillations in depression.

Authors:  Otis Lkuwamy Smart; Vineet Ravi Tiruvadi; Helen S Mayberg
Journal:  Biol Psychiatry       Date:  2015-01-28       Impact factor: 13.382

6.  Frontal theta and posterior alpha in resting EEG: A critical examination of convergent and discriminant validity.

Authors:  Ezra E Smith; Craig E Tenke; Patricia J Deldin; Madhukar H Trivedi; Myrna M Weissman; Randy P Auerbach; Gerard E Bruder; Diego A Pizzagalli; Jürgen Kayser
Journal:  Psychophysiology       Date:  2019-10-02       Impact factor: 4.016

7.  α Power, α asymmetry and anterior cingulate cortex activity in depressed males and females.

Authors:  Natalia Jaworska; Pierre Blier; Wendy Fusee; Verner Knott
Journal:  J Psychiatr Res       Date:  2012-08-28       Impact factor: 4.791

8.  Electroencephalographic Biomarkers for Treatment Response Prediction in Major Depressive Illness: A Meta-Analysis.

Authors:  Alik S Widge; M Taha Bilge; Rebecca Montana; Weilynn Chang; Carolyn I Rodriguez; Thilo Deckersbach; Linda L Carpenter; Ned H Kalin; Charles B Nemeroff
Journal:  Am J Psychiatry       Date:  2018-10-03       Impact factor: 18.112

9.  Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder.

Authors:  Jakub Z Konarski; Sidney H Kennedy; Zindel V Segal; Mark A Lau; Peter J Bieling; Roger S McIntyre; Helen S Mayberg
Journal:  J Psychiatry Neurosci       Date:  2009-05       Impact factor: 6.186

10.  Midline and right frontal brain function as a physiologic biomarker of remission in major depression.

Authors:  Ian A Cook; Aimee M Hunter; Michelle Abrams; Barbara Siegman; Andrew F Leuchter
Journal:  Psychiatry Res       Date:  2009-10-22       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.